期刊文献+

术前静脉注射氯诺昔康对子宫切除术患者围术期血浆RANTES浓度的影响 被引量:1

Effect of preoperative intravenous lornoxicam on plasma concentration of T-cell expressed and secreted regulatory activating factor during perioperative period
原文传递
导出
摘要 目的探讨术前静脉注射氯诺昔康对子宫切除术患者围术期血浆T细胞表达和分泌的调节性激活因子(RANTES)浓度的影响。方法择期行子宫切除术患者30例,随机分为3组(n=10),对照组(C组),氯诺昔康8 mg组(L8组)麻醉前单次静脉注射氯诺昔康8 mg,氯诺昔康16 mg组(L16组)麻醉前单次静脉注射氯诺昔康16 mg。分别在开放静脉前(T0)、切皮后30 min(T1)、术毕(T2)、术后24 h(T3)和术后48 h(T4)采集外周静脉血,测定血浆RANTES的浓度。结果与T0时比较,C组、L8组、L16组在T1~T3时血浆RANTES浓度降低(P〈0.05);与C组比较,L8组、L16组血浆RANTES浓度升高(P〈0.05);与L8组比较,L16组血浆RANTES浓度升高(P〈0.05),呈剂量依赖性。结论术前静脉注射氯诺昔康16 mg可抑制子宫切除术患者围术期血浆RANTES浓度的下降,提示可能有助于维持细胞免疫功能的稳定。 Objective To investigate the effect of intravenous lornoxicam given before operation on plasma concentration of T cell expressed and secreted regulatory activating factor (RANTES) during perioperative period. Methods Thirty ASA Ⅰ or Ⅱ patients aged 33-59 yr weighing 44-73 kg undergoing elective hysterectomy were randomly divided into 3 groups ( n = 10 each) : group Ⅰ control; group Ⅱ received lornoxicam 8 mg iv before operation (L8 ) and group Ⅲ received lornoxicam 16 mg iv before operation (L16) . The patients were premedicated with intramuscular sodium phenobarbital 0.1 g atopine 0.5 mg. Continuous epidural anesthesia was performed at L2,3 interspace. Correct epidural catheter placement was confirmed by giving a test dose of 2% lidocaine 5 ml. Then a mixture of 0.25 % tetracaine and 1% lidocaine 12-15 ml was injected for epidural block. The sensory block extended from T6 to L3 . All of the patients received epidural analgesia with a mixture of ropivacaine 150 mg and morphine 4 mg in 100 ml normal saline (loading dose 5 ml, background infusion 2 ml/h) after operation for 50 h. Blood samples were taken before anesthesia ( To , baseline), at 30 min after skin incision ( T1 ), at the end of operation (T2) and 24 h and 48 h after operation ( T3 , T4 ) for determination of plasma RANTES concentration. Results The plasma RANTES concentrations were significantly decreased at T1,3 as compared to the baseline values at To in all 3 groups and were significantly higher in the 2 lornoxicam groups than in control groups dosedependently. Conclusion Lornoxicam 16 mg given iv before hysterectomy can significantly inhibit the decrease in plasma RANTES concentration induced by operation and help maintain the stability Of cellular immune function of the patients.
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2007年第9期789-791,共3页 Chinese Journal of Anesthesiology
基金 江苏省医学重点人才资助项目(RC2002058) 苏州市科教兴卫青年专项基金资助项目(SWQ21)
关键词 消炎药 非甾类 炎症趋化因子类 子宫切除术 手术期间 Anti-inflammatory agents, non-steroidal Chemokines Hysterectomy Intraoperative period
  • 相关文献

参考文献9

  • 1Memis D, Karamanlioglu B, Turan A, et al. Effects of lomoxicam on the physiology of severe sepsis. Crit Care, 2004,8 : R474-482.
  • 2谭武菊,牛新环,李刚,傅志俭,孙巧梅.氯诺昔康对食管癌切除术病人围术期自然杀伤细胞及淋巴细胞亚群的影响[J].中华麻醉学杂志,2006,26(1):84-85. 被引量:8
  • 3Hofstetter C, Flondor M, Boost KA, et al. A brief exposure to isoflurane (50 s) significantly impacts on plasma cytokine levels in endotoxemic rats. Int Immunopharmacol, 2005, 5 : 1519-1522.
  • 4Wang ZY, Wang CQ, Yang JJ, et al. Which has the least immunity depression during postoperative analgesia: morphine, tramadol, or tramadol with lomoxicam? Clin Chim Acta, 2006,369:40-45.
  • 5王忠云,黄亚辉,钱燕宁.氯诺昔康对胃癌患者术后曲马多镇痛的影响[J].临床麻醉学杂志,2003,19(10):604-606. 被引量:36
  • 6Code W. NSAIDs and balanced analgesia. Can J Anaesth, 1993,40: 401-405.
  • 7Lotan D, Zilberman D, Dagan O, et al. Beta-chemokine secretion patterns in relation to clinical course and outcome in children after eardiopulmonary bypass: continuing the search to abrogate systemic inflammatory response. Ann Thorac Surg,2001,71:233-237.
  • 8Ogawa K, Hirai M, Katsube T, et al. Suppression of celluar immunity by surgical stress. Surgery, 2.000,127 : 329-336.
  • 9Tegeder I, Pfeilschifler J, Geisslinger G. Cyclooxygenase-independent actions of the cyclooxygenase inhibitors. FASEB J, 2001,15:2057-2072.

二级参考文献18

  • 1陈真福,吴善苏,谢治己,陈启忠,魏秀吾,钟进财,上官明化.三种不同浓度的氯诺昔康和吗啡用于静脉镇痛的比较[J].临床麻醉学杂志,2004,20(12):713-715. 被引量:5
  • 2Skjodt NM, Davies NM. Clinical pharmacokinetics of lornoxicam. A short half-life oxicam. Clin Pharmacokinet,1998,34: 421-428.
  • 3Pruss TP, Stroissnig H, Radhofer-Welte S, et al. Overview of the pharmacological properties, pharmacokinetics and animal safety assessment of lornoxicam. Postgrad Med J,1990,66(Suppl 4) : 18-21.
  • 4Kehlet H,Werner M, Perkins F. Balanced analgesia. Whatis it and what are its advantages in postoperative pain?Drugs, 1999,58 : 793-797.
  • 5McCormack K. Non-steroidal anti-inflammatory drugs and spinal nociceptive processing. Pain, 1994,59 : 6-43.
  • 6Kullich W,Klein G. Influence of the nonsteroidal anti-inflammatory drug lornoxicam on the secretion of the endogenos opiatc peptides dynorphin and β-endorphin. Aktuel Rheumatol, 1992,17 : 128-132.
  • 7Code W. NASIDs and balanced analgesia. Can J Anaesth, 1993,40 : 401-405.
  • 8Kata J, McCartney CJL. Current status of pre-emptive analgesia. Curr Opin Anaesthesiol, 2002,15 : 435-441.
  • 9Driessen B, Reimann. Interaction of the central analgesic tramadol, with the uptake and release of 5-hydroxytrptamine in the rat brain in vitro. Br J Pharmacol, 1992,105 : 147-151.
  • 10Amano H,Hayashi I,Endo H,et al.Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth.J Exp Med,2003,197:221-232.

共引文献40

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部